Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r.
The melanocortin-1 receptor (MC1R) is a key regulator of pigmentation in mammals and is tightly linked to an increased risk of skin cancers, including melanoma, in humans. Physiologically activated by alpha-melanocyte stimulating hormone (alphaMSH), MC1R function can be antagonized by a secreted factor, agouti signal protein (ASP), which is responsible for the lighter phenotypes in mammals (including humans), and is also associated with increased risk of skin cancer. It is therefore of great interest to characterize the molecular effects elicited by those MC1R ligands. In this study, we determined the gene expression profiles of murine melan-a melanocytes treated with ASP or alphaMSH over a 4-day time course using genome-wide oligonucleotide microarrays. As expected, there were significant reductions in expression of numerous melanogenic proteins elicited by ASP, which correlates with its inhibition of pigmentation. ASP also unexpectedly modulated the expression of genes involved in various other cellular pathways, including glutathione synthesis and redox metabolism. Many genes up-regulated by ASP are involved in morphogenesis (especially in nervous system development), cell adhesion, and extracellular matrix-receptor interactions. Concomitantly, ASP enhanced the migratory potential and the invasiveness of melanocytic cells in vitro. These results demonstrate the role of ASP in the dedifferentiation of melanocytes, identify pigment-related genes targeted by ASP and by alphaMSH, and provide insights into the pleiotropic molecular effects of MC1R signaling that may function during development and may affect skin cancer risk.
Le Pape
Elodie
E
Pigment Cell Biology Section, Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Passeron
Thierry
T
Giubellino
Alessio
A
Valencia
Julio C
JC
Wolber
Rainer
R
Hearing
Vincent J
VJ
D054366:Agouti Signaling Protein / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D002454:Cell Differentiation; D002465:Cell Movement / Q000187:drug effects; D004198:Disease Susceptibility; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects; D023281:Genomics; D008024:Ligands; D008544:Melanocytes / Q000166:cytology*; D051379:Mice; D020411:Oligonucleotide Array Sequence Analysis; D010858:Pigmentation / Q000187:drug effects / Q000235:genetics; D044102:Receptor, Melanocortin, Type 1 / Q000378:metabolism*; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000209:etiology; D000521:alpha-MSH / Q000494:pharmacology
D054366:Agouti Signaling Protein; D008024:Ligands; D044102:Receptor, Melanocortin, Type 1; D000521:alpha-MSH